Malantig, Xyrus L.
HRN: 21-57-08 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2023
CEFTRIAXONE 1G (VIAL)
07/28/2023
08/04/2023
IV
640mg
Q 24H
T/C HAP W/ Concurrent PCAP
Checking Final Appropriateness